Public Health Need, Molecular Targets, and Opportunities for the Accelerated Development of Function-Promoting Therapies: Proceedings of a National Institute on Aging Workshop.

Published in: The journals of gerontology. Series A, Biological sciences and medical sciences (2022)

Function-promoting therapies to prevent and treat physical disabilities associated with aging and chronic diseases are a public health imperative. Appropriately powered, well-designed clinical trials and synergistic collaboration among academic experts, patients and stakeholders, the NIH and the FDA, and the pharmaceutical industry are needed to accelerate the development of function-promoting therapies.

Keyphrases

public health
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
physical activity
peritoneal dialysis
drug delivery
open label
medical students
double blind
phase ii